Register entry
- Registered sites
- 3
- Active NDC listings
- 3
- Labeller names
- 2
- Live patents
- 0
- Countries
- 2
- Base
- United States
Authorisation
Registered operations
Analytical testing3Labelling2Finished drug manufacture3Packaging2
Sites
Registered establishments
3| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| Emergent BioSolutions Canada IncRegistrant: Emergent BioSolutions Inc. | 155 Innovation Drive, Winnipeg, Manitoba R3T5Y3, Canada (CAN) | Analytical testing, Labelling, Finished drug manufacture, Packaging | 3003153579203508049 |
| Emergent Biodefense Operations Lansing LLCRegistrant: Emergent BioSolutions Inc. | 50 Shawmut Rd, Canton, Massachusetts (MA) 02021, United States (USA) | Analytical testing, Finished drug manufacture | 3004051669081005624 |
| Emergent Biodefense Operations Lansing LLCRegistrant: Emergent BioSolutions Inc. | 3500 North Martin Luther King Jr Blvd, Lansing, Michigan (MI) 48906, United States (USA) | Analytical testing, Labelling, Finished drug manufacture, Packaging | 1873886026489018 |
Catalogue
Drug listings by form and route
33 active NDC listings: 2 plasma derivative, 1 human prescription drug. By marketing category: BLA 3.
| Dosage form | NDCs |
|---|---|
| liquid | 2 |
| injection | 1 |
| Route | NDCs |
|---|---|
| intravenous | 3 |
| Labeller name on the listing | NDCs |
|---|---|
| emergent biosolutions canada inc. | 2 |
| emergent biosolutions canada inc | 1 |
Catalogue
Marketed products
3| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| Anthrasil | Anthrax immune globulin (human) | liquid, intravenous | 60492-0249BLA |
| BAT | Botulism Antitoxin Heptavalent | liquid, intravenous | 60492-0075BLA |
| CNJ-016 | Vaccinia Immune Globulin Intravenous (Human) | injection, intravenous | 60492-0173BLA |
Neighbours
Registered in the same town
3- Solvias North America, LLCCanton, MA
- Armstrong Pharmaceuticals, Inc.Canton, MA
- Genvion CorporationWinnipeg, CAN
Compare
Comparable companies in United States
- International Medication Systems, Ltd.3 sites · 2,801 NDC
- Alk-Abello, Inc.3 sites · 412 NDC
- Conopco, Inc. d/b/a Unilever3 sites · 374 NDC
- L. Perrigo Company3 sites · 243 NDC
- Epic Laboratories, LLC3 sites · 209 NDC
- Safecor Health, LLC3 sites · 103 NDC
- ProPharma Distribution, LLC.3 sites · 100 NDC
- B. Braun US Pharmaceutical Manufacturing LLC3 sites · 94 NDC
- Aurolife Pharma LLC3 sites · 70 NDC
- Elementis Specialties (India) Private Limited3 sites · 69 NDC
Enquiry
Common questions
- Is Emergent BioSolutions Inc. FDA approved?
- Emergent BioSolutions Inc. holds 3 FDA-registered establishments across 2 countries. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are Emergent BioSolutions Inc.'s drugs manufactured?
- At registered sites in Canada, the United States. The FDA register lists Winnipeg; Canton, MA; Lansing, MI. Registered operations: analytical testing, labelling, finished drug manufacture, packaging.
- What drugs does Emergent BioSolutions Inc. make?
- 3 products are listed under Emergent BioSolutions Inc. in the openFDA NDC Directory, most often as liquid; injection. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.